Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jun;43(6):1154-1156.
doi: 10.1111/liv.15582.

Carvedilol, probably the β-blocker of choice for everyone with cirrhosis and portal hypertension: But not so fast!

Càndid Villanueva  1   2 , Dhiraj Tripathi  3   4   5
Affiliations
Editorial

Carvedilol, probably the β-blocker of choice for everyone with cirrhosis and portal hypertension: But not so fast!

Càndid Villanueva et al. Liver Int. 2023 Jun.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. De Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII-renewing consensus in portal hypertension. J Hepatol. 2022;76:959-974.
    1. Tripathi D, Hayes PC. Beta-blockers in portal hypertension: new developments and controversies. Liver Int. 2014;34:655-667.
    1. Turco L, Reiberger T, Giovanni V, La Mura V. Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertension. Liver Int. 2023;43. doi:10.1111/liv.15559
    1. Bosch J, Groszmann RJ, Shah VH. Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments. J Hepatol. 2015;62:S121-S130.
    1. D'Amico G, Pasta L, Morabito A, et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther. 2014;39:1180-1193.

MeSH terms

LinkOut - more resources